|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 211/24 | |
| A61K 31/445 | |||
| A61P 25/28 |
| (11) | Number of the document | 2753603 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12755869.0 |
| Date of filing the European patent application | 2012-09-06 | |
| (97) | Date of publication of the European application | 2014-07-16 |
| (45) | Date of publication and mention of the grant of the patent | 2017-06-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2012/067371 |
| Date | 2012-09-06 |
| (87) | Number | WO 2013/034622 |
| Date | 2013-03-14 |
| (30) | Number | Date | Country code |
| 201170496 | 2011-09-07 | DK | |
| 201161533550 P | 2011-09-12 | US |
| (72) |
SONESSON, Clas, SE
PITTELKOW, Thomas, DK
FR STRUP, Brian, DK
ZIMMERMANN, Anne, DK
|
| (73) |
Teva Pharmaceuticals International GmbH,
Schlüsselstrasse 12, 8645 Jona,
CH
|
| (54) | POLYMORPHIC FORM OF PRIDOPIDINE HYDROCHLORIDE |
| POLYMORPHIC FORM OF PRIDOPIDINE HYDROCHLORIDE |